A Single Group Study to Evaluate the Efficacy of Bye Bye Bloat Capsules in Relieving Bloating and Promoting Healthy Digestion.
- Conditions
- DigestionDigestive Health
- Interventions
- Dietary Supplement: Bye Bye Bloat Capsules
- Registration Number
- NCT06516744
- Lead Sponsor
- Love Wellness
- Brief Summary
This virtual single-group study aims to evaluate the efficacy of Bye Bye Bloat Capsules in relieving hormonal and food-related bloating and promoting healthy digestion. The study will last 4 weeks, involving 40 female participants aged 18+ who will take two capsules after meals and during times of bloating. Measurements and questionnaires will be completed at Baseline, first use, Week 2, and Week 4.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
- Women aged 18+
- Self-reported concerns with bloating after eating
- Issues with hormonal bloating
- Generally healthy without uncontrolled chronic diseases
- Willing to avoid using digestive health remedies and other oral supplements during the study
- Pre-existing chronic conditions preventing adherence to the protocol
- Undergoing procedures related to digestive health
- Started new medications or supplements targeting digestive health in the past 3 months
- Severe allergic reactions requiring an Epi-Pen
- Pregnant, breastfeeding, or attempting to conceive
- Unwilling to follow the study protocol
- Recent surgeries or planned surgeries during the study
- Diagnosed gastrointestinal disorders
- Recent changes in hormonal birth control use
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Bye Bye Bloat Capsules Bye Bye Bloat Capsules Participants will take 2 Bye Bye Bloat capsules immediately after eating (when they feel full and bloated) at least 3 times a week. They may also take the product during times of hormonal bloating. The study will last for 4 weeks, with questionnaires and waist measurements completed at Baseline, first use, Week 2, and Week 4.
- Primary Outcome Measures
Name Time Method Reduction in Bloating Baseline, first use, Week 2, and Week 4 Evaluation of parameters associated with hormonal and food-related bloating through self-reported questionnaires taken at Baseline, first use, Week 2, and Week 4.
- Secondary Outcome Measures
Name Time Method Improvement in Digestion and Mental Well-being Baseline, first use, Week 2, and Week 4 Assessment of changes in participant perception of digestion, gas, mental health, and well-being associated with bloating through self-reported questionnaires taken at Baseline, first use, Week 2, and Week 4.
Trial Locations
- Locations (1)
Citruslabs
🇺🇸Santa Monica, California, United States